MPH HEALTH CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.6 EUR | -2.83% |
|
+5.64% | +25.61% |
| 02-05 | M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares | MT |
| 2023 | MPH Health Care AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2023 * | 29.89M 31.96M 2.56B | Sales 2024 * | 37.08M 39.65M 3.18B | Capitalization | 88.2M 94.3M 7.55B |
|---|---|---|---|---|---|
| Net income 2023 * | 26M 27.8M 2.23B | Net income 2024 * | 33M 35.28M 2.83B | EV / Sales 2023 * | 2.95 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 2.38 x |
| P/E ratio 2023 * |
33.2
x | P/E ratio 2024 * |
26.1
x | Employees | 1 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 40% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.83% | ||
| 1 week | +5.64% | ||
| Current month | -1.90% | ||
| 3 months | +24.85% | ||
| 6 months | +43.06% | ||
| Current year | +25.61% |
1 week
20.40
21.20
1 month
19.5022.20
Current year
15.9025.50
1 year
13.6525.50
3 years
9.1031.20
5 years
9.1043.70
10 years
9.1053.70
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 20.6 | -2.83% | 0 |
| 25/04/24 | 21.2 | +3.92% | 0 |
| 24/04/24 | 20.4 | -1.92% | 0 |
| 23/04/24 | 20.8 | -0.95% | 0 |
| 22/04/24 | 21 | +7.69% | 0 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 08:05 am
More quotes
MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
20.6
EUR
Average target price
62
EUR
Spread / Average Target
+200.97%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 94.16M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- 93M1 Stock
